Introduction

 

 

Since the 4th industrial revolution has lately become the important issue, discussions on 

the use of big data are flourishing. 

 
​There is always a race against time to develop a new type of drug. 

If a pharmaceutical company desires to develop a new, innovative drug, a 10 to 15 year 

time period and development costs of approximately 1 trillion won should be invested. 

However, the development of a new drug only has a success rate of 0.02%. In general, 

the new drug development process proceeds through several stages: Look for a new drug 

candidate substance and go through phase 1 – 3 clinical tests after preclinical animal tests.

 
​'Big Data” is suggested as an alternative to decrease costs and time for the new drug 

development. The probability of failure in clinical tests also decreases, as a patient suitable for 

such tests using the genetic big data can be found. Moreover, effects of such relevant new 

drug compared to existing drugs can be predicted.

 
Even our government declared that it would hold the ‘5th meeting of the public-private 

consultative group for Bio-health Industry Promotion’ and establish the strategy for use of 

big data in health and medical treatment so as to utilize medical big data as the new drug 

development. It also planned to support analysis consulting that collects, manages and 

operates the data accumulated based on the national health insurance as the big data, 

in which nongovernmental industries desire. However, we still have many outstanding issues 

such as policy to resolve before using the medial big data. 

  
​Through this upcoming 9th Seoul International New Pharmaceuticals Forum, we are going to 

examine how global pharmaceutical companies use the medial big data for the new drug 

development. Also we will look for ways of using the medical big data offered by 

the government and find if there is any problem in terms of policies.

 

 

 

Overview

 

 

Title : The 9th Seoul International New Pharmaceuticals Forum

 

Theme : New Drug Development Using Medical Big Data

 

Date : June 15th, 2017(Thu) / 09:00 ~ 14:00

 

Venue : Grand Ballroom, Conrad Hotel, Seoul

 

Host : The Financial News, Korea Research Institute of Chemical Technology

 

Supporters : Ministry of Health and Welfare, Ministry of Science, ICT and Future Planning,

                      ​Ministry of Food and Drug Safety, Korea Pharmaceutical Manufacturers Association,

                      Korea Biotechnology Industry Organization, ​Korea Research-based Pharmaceutical

                      Industry Association